UCPB associates and their qualified dependents are set to benefit from the Moderna Covid19 mRNA-1273 vaccine after 11,500 dosages were acquired for their protection. This is one of the Bank’s initiatives in support of government’s efforts to fight the pandemic.
Based on the agreement with the ICTSI Foundation and the Moderna Buyers’ Group, the vaccines will start arriving by mid-June and the delivery and administration of the vaccine at Zuellig Pharma’s accredited vaccination sites are expected to be completed by the end of the year. The cost will be covered by the associates’ annual medical benefit. Associates who also signed up their relatives or other household members have an option to pay through salary deduction or salary loan. The vaccines will also be made available to the Bank’s security guards and utility personnel.
UCPB Officer-in-Charge Liduvino S. Geron underscored the importance of UCPB associates receiving the vaccines. “Our associates are the Bank’s greatest asset. I have seen their dedication to their work and their clients amidst this pandemic. We want to make sure they have the best fighting chance against the virus by securing the vaccines at the earliest possible time to ensure their health and safety.”
Since the pandemic started in March 2020, UCPB has strictly enforced health standards and protocols in the Head Office and branches including physical distancing, sanitation and hygiene; stringent stay-at-home guidelines for those with symptoms or suspected exposure; monitoring/quarantine of suspect, probable or positive cases. The Bank also adopted alternative work arrangements such as the Work-From-Home/Work-On-Site set-up, staggered work schedules, and compressed work week to lessen the associates’ exposure to the virus.
Date published: June 1, 2021